Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

10 Nov 2022 09:42

RNS Number : 9939F
Mandarin Oriental International Ltd
10 November 2022
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

10th November 2022 - Mandarin Oriental International Limited today issues its Interim Management Statement for the third quarter of 2022.

 

The return of normal travel conditions in most of the world in early 2022 saw the Group record net underlying profits (unaudited) in the second quarter, and this progress continued in the third quarter.

 

In the Group's owned hotels, improvements in occupancy and high rates resulted in a stronger performance in the third quarter. This drove increased profitability compared to the second quarter, particularly in Paris and Munich. Two of the Group's key profit-generating hotels, in Hong Kong and Tokyo, however, remained subject to stringent travel restrictions throughout the third quarter, which significantly impacted operating performance. The hotels in Bangkok and Singapore continued their recovery following the removal of travel barriers.

 

The performance of the management business was strong in the third quarter and it recorded a significant improvement in profitability compared to the second quarter. Of particular note were the contributions made by a number of the Group's Mediterranean and Middle Eastern properties.

 

As a result of the improved trading conditions and Mandarin Oriental's expanded portfolio of hotels and residences, the Group recorded its highest quarterly EBITDA since 2019. Both the owned hotels and the management business delivered higher EBITDA than in the second quarter of 2022.

 

In September 2022, the Group opened Mandarin Oriental Palace, Luzern, its second hotel in Switzerland, and its standalone residences project in Barcelona. Recently, the Group announced a new hotel in Tianfu, the new business district of Chengdu, further expanding its presence in China. On 8th September 2022, the Group completed the sale of Mandarin Oriental, Washington D.C., for US$139 million. As a result, the Group has recognised a post-tax, non-trading gain in the third quarter of US$47 million.

 

Following the disposal, net debt at 30th September 2022 reduced to US$385 million (US$519 million at 30th June 2022), and the Group held US$267 million of cash reserves and US$472 million in available, committed debt facilities. Gearing was 8% of adjusted shareholders' funds.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKBLBFLFLXFBK
Date   Source Headline
9th Oct 202410:22 amRNSAdditional Listing
7th Oct 202411:45 amRNSDirector/PDMR Shareholding
2nd Oct 202410:24 amRNSDividend
27th Sep 202411:30 amRNSDividend
25th Sep 202410:40 amRNSBlock listing Interim Review
23rd Sep 20241:01 pmRNSDisposal of Shares in Yonghui Superstores
9th Sep 202410:27 amRNSDirector/PDMR Shareholding
4th Sep 202410:21 amRNSCirc re. Scrip Dividend Scheme
14th Aug 202411:08 amRNSDirector/PDMR Shareholding
1st Aug 202412:22 pmRNSHalf-Year Results
1st Aug 202410:56 amRNSJC&C 2024 Half-Year Results
1st Aug 202410:39 amRNSHalf-Year Results
1st Aug 202410:22 amRNSHalf-Year Results
31st Jul 202411:10 amRNSPT HERO SUPERMARKET TBK FIRST HALF 2024 RESULTS
30th Jul 202411:06 amRNSPT Astra 2024 First Half Financial Statements
24th Jul 20243:06 pmRNSHalf-year Report
2nd Jul 20241:12 pmRNSDirector/PDMR Shareholding
28th Jun 202410:25 amRNSDirector/PDMR Shareholding
27th Jun 202410:28 amRNSEXTRACTIVE SECTOR: PAYMENTS TO GOVTS REPORT 2023
26th Jun 202410:29 amRNSDirector/PDMR Shareholding
26th Jun 202410:28 amRNSDirector/PDMR Shareholding
24th Jun 202410:25 amRNSDirector/PDMR Shareholding
21st Jun 202410:30 amRNSDirector/PDMR Shareholding
19th Jun 202410:27 amRNSDirector/PDMR Shareholding
19th Jun 202410:24 amRNSDirector/PDMR Shareholding
17th Jun 202410:29 amRNSDirector/PDMR Shareholding
12th Jun 202411:59 amRNSDisposal
12th Jun 202410:22 amRNSDirector/PDMR Shareholding
7th Jun 202410:27 amRNSDirector/PDMR Shareholding
5th Jun 202410:36 amRNSDirector/PDMR Shareholding
4th Jun 202410:20 amRNSDirector/PDMR Shareholding
3rd Jun 202412:08 pmRNSDirector/PDMR Shareholding
31st May 202411:26 amRNSTotal Voting Rights
28th May 202411:34 amRNSTransaction in Own Shares
23rd May 202410:54 amRNSInterim Management Statement
23rd May 202410:44 amRNSINTERIM MANAGEMENT STATEMENT
23rd May 202410:37 amRNSINTERIM MANAGEMENT STATEMENT
23rd May 202410:34 amRNSINTERIM MANAGEMENT STATEMENT
21st May 202410:31 amRNSHolding(s) in Company
17th May 202410:42 amRNSDirector/PDMR Shareholding
16th May 202411:53 amRNSTransaction in Own Shares
15th May 202412:43 pmRNSTotal Voting Rights
14th May 202411:38 amRNSTransaction in Own Shares
13th May 20241:29 pmRNSTransaction in Own Shares
10th May 202411:49 amRNSTransaction in Own Shares
9th May 202411:41 amRNSTransaction in Own Shares
9th May 202411:19 amRNSAdditional Listing
8th May 20241:15 pmRNSResult of AGM
8th May 202411:28 amRNSTransaction in Own Shares
7th May 202412:27 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.